SC asks Centre, states to list out steps to curb leprosy

Image
Press Trust of India New Delhi
Last Updated : Jan 13 2015 | 6:40 PM IST
Supreme Court today asked the Centre and state governments to apprise it of steps taken to eradicate and curb leprosy, saying it was their responsibility to curb the spread of the disease which is curable.
A bench comprising justices Dipak Misra and Prafulla C Pant sought responses from the Union Health Ministry and state administrations within four weeks.
The bench then fixed March 16 for hearing the PIL filed by advocate Pankaj Sinha in his personal capacity.
The court had earlier rapped the authorities for their "apathy" in eradicating leprosy from the country, saying despite it being "curable", the disease still remains a stigma.
Earlier too, the bench had granted time for filing of replies by the Centre and others and had said, "This is a case which should have been taken on priority basis. Leprosy, as on today, is curable and yet because of apathy shown by the authorities concerned, it still remains a stigma."
Sinha, in his plea, has alleged that leprosy affects over 1.25 lakh people annually in the country.
He also alleged that governments have failed to eliminate the disease despite medical treatment available since 1981.
"Despite an effective cure, namely Multi-Drug Therapy (MDT) which has been available since 1981, that can completely cure 99 per cent of leprosy bacteria, due to apathy of the Government of India and the State Governments, people are still suffering from the said disease, which is treated as a social stigma," the petition said.
It has sought a direction to the governments that drugs be made available at primary health centres in the country.
It also pleaded that an appropriate scheme be formulated to bring people suffering from leprosy into the national mainstream.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 13 2015 | 6:40 PM IST

Next Story